New 'Viagra for the brain' pill slows clinical decline in Alzheimer's patients by a third

dailymail.co.uk · health
Full story

A new pill designed to treat Alzheimer's patients has shown a reduction in clinical decline by one third. In a major phase III trial, the therapy delayed the progression of the disease. This effect was equivalent to 3.5 months after one year of use.

The blockbuster therapy delayed progression of the disease by the equivalent of 3.5 months after just one year in a major phase III trial.

Read full article → Compare